HCA Healthcare Inc (NYSE:HCA)
$ 410.5 +17.26 (+4.39%) Market Cap: 91.07 Bil Enterprise Value: 143.30 Bil PE Ratio: 14.12 PB Ratio: 0 GF Score: 87/100

Q4 2025 HCA Healthcare Inc Earnings Call Transcript

Jan 27, 2026 / 03:00PM GMT
Release Date Price: $505.84 (+7.08%)

Key Points

Positve
  • HCA Healthcare Inc (HCA) reported a 6.7% increase in revenue compared to the prior year quarter, demonstrating strong financial performance.
  • Net income attributable to HCA Healthcare increased by almost 31%, and diluted earnings per share as adjusted increased by 29%.
  • The company achieved its 19th consecutive quarter of volume growth, indicating sustained demand across its markets.
  • HCA Healthcare invested significantly in network expansion, workforce development, and clinical capabilities, resulting in approximately 47 million patient encounters in 2025.
  • The company has a robust resiliency program focusing on revenue integrity, cost efficiencies, and capacity management, which is expected to generate $400 million in cost savings in 2026.
Negative
  • Outpatient surgical volume declined slightly, and inpatient surgeries were flat, indicating potential challenges in surgical services growth.
  • The expiration of enhanced premium tax credits and administrative reforms are expected to have an adverse impact on adjusted EBITDA between $600 million and $900 million in 2026.
  • HCA Healthcare anticipates a decline in supplemental payment programs' net benefit between $250 million and $450 million, affecting financial performance.
  • The company faces continued physician cost pressures, with expectations of high single-digit growth in these costs for 2026.
  • There is uncertainty regarding the impact of exchange reforms and subsidy expirations on volume outlook, with potential declines in utilization from individuals losing coverage.
Operator

Ladies and gentlemen, welcome to HCA Healthcare fourth quarter 2025 earnings conference call. Today's call is being recorded.

At this time, for opening remarks and introductions, I would like to turn the call over to Vice President of Investor Relations, Mr. Frank Morgan. Please go ahead, sir.

Frank Morgan
HCA Healthcare Inc - Vice President - Investor Relations

Good morning, and welcome to everyone on today's call. With me this morning is our CEO, Sam Hazen; and CFO, Mike Marks. Sam and Mike will provide some prepared remarks, and then we'll take questions.

Before I turn the call over to Sam, let me remind everyone that should today's call can take any forward-looking statements that are based on management's current expectations. Numerous risks, uncertainties, and other factors may cause actual results to differ materially from those that might be expressed today. More information on forward-looking statements and these factors are listed in today's press release and in our various SEC filings.

On this morning's call, we may

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot